NFE2L2 and Hyperglycemia: SFN treatment increased the expression of Nrf2 and downstream effectors in HT22 cells and reversed the increased ROS levels, indicating that the Nrf2 pathway is essential for the maintenance of cell function, which is impaired under hyperglycaemia (Fig. 8).